SPON2 and colorectal carcinoma: The Kaplan-Meier survival analysis revealed that the positive expression of SPON2 protein in cancerous epithelial cells indicated a worse prognosis of CRC patients (Log-rank test = 4.381, p = 0.036) (Figure 3C).